Failure to document blood sugars, rotate insulin sites, and monitor psychotropic medications
Summary
The facility failed to meet professional standards of care for three sampled residents involving insulin administration, blood sugar documentation, and psychotropic medication monitoring. Resident 2 was admitted with diagnoses including diabetes mellitus and depression, had intact cognition, and had an active order for Lantus at bedtime with instructions to hold the insulin when blood sugar was less than 100. Review of the resident’s blood sugar summary and MAR showed no blood sugar reading documented at bedtime on multiple dates in May 2026, and the DON and MDSD confirmed the missing documentation. The DON stated the blood sugar level should be checked and documented before insulin administration and that documentation was proof of action. Resident 2’s insulin administration history also showed repeated use of the left lower abdomen for consecutive days rather than rotation of the injection site. The MDSD stated the resident received Lantus in the left lower abdomen for three consecutive days on two separate occasions and for two consecutive days on another occasion. The MDSD stated the facility’s practice was to rotate insulin administration sites to minimize discoloration, pain, and wound formation. Resident 36 was admitted with diagnoses including psychosis and depression, lacked capacity to make and understand medical decisions, and had severely impaired cognition. The resident had orders for citalopram hydrobromide daily and quetiapine fumarate at bedtime. Review of the MAR showed the resident received the ordered doses, but there was no documentation for psychotropic medication monitoring on the MAR for the month reviewed. The MDSD and DON stated staff were expected to monitor behavior every shift and document it on the MAR, including monitoring for therapeutic effectiveness, behavioral response, adverse reactions or side effects, and changes in cognition, mood, appetite, sleep, functional status, and signs of over-sedation. Resident 7 had diagnoses including type 2 diabetes mellitus, chronic kidney disease, and hemiplegia. The resident had an order for insulin asparte before meals and at bedtime depending on blood sugar levels, with instructions to rotate the injection site each time insulin was given. Review of the Location of Administration Reports for March and May 2026 showed insulin was administered at the same injection sites on multiple dates without rotation. The DON and RN stated that insulin sites should be rotated after each injection to prevent bruising and hardening of subcutaneous tissue and that repeated injections at the same site could cause irritation, pain, or swelling.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.